Nasus Pharma has filed for an initial public offering. The pharmaceutical company plans to offer 1 million units at $10 to $12 apiece for total proceeds of up to $12 million, according to a filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback